Details for 2017826645
Up to date per 03.04.2026
Actions
Details for 2017826645
Granted/Registered
European Patent
23.10.2019 A
17.08.2022 B1
19.12.2016
US
201662436223 P
06.01.2017
US
201762443484 P
30.03.2017
US
201762479178 P
22.09.2017
US
201762562146 P
A61K 47/64 20170101AFI20220207BHEP
Owner
Sarepta Therapeutics, Inc.215 First Street, Suite 415 Cambridge, MA 02142US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
PASSINI, Marco, A.215 First Street Suite 415 Cambridge, MA 02142US
HANSON, Gunnar, J.215 First Street Suite 415 Cambridge, MA 02142US
Information about Fees